[Double-blind study of a corticoid combination as compared with the single components in the hematologic field: preliminary data].
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001623:Betamethasone / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D005069:Evaluation Studies as Topic; D005260:Female; D006402:Hematologic Diseases / Q000188:drug therapy*; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D011239:Prednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D004338:Drug Combinations; D001623:Betamethasone; D011239:Prednisolone; D011241:Prednisone
Confronto "double-blind" di un'associazione cortisonica con i singoli componenti in campo ematologico: dati preliminari.